Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Charles Bon

Charles Bon

Biostudy Solutions LLC USA

Adam Sabouni

Adam Sabouni

PharmaConsultz, USA

Philip Armendi

Philip Armendi

Allergan USA

Kurt R Karst

Kurt R Karst

Hyman Phelps and McNamara P C USA

Murray Ducharme

Murray Ducharme

Learn & Confirm Inc. Canada

Mohammad Refaat Khattab

Mohammad Refaat Khattab

Texas A&M University USA

Olubunmi Ogbodu

Olubunmi Ogbodu

University of Venda South Africa

Jianguo Yang

Jianguo Yang

Abpro China

Generics-Biosimilars 2017

Sessions/Tracks

Conference Series LLC invites all the participants from all over the world to attend “2nd International Conference on Generic Drugs and Biosimilars August 24-25, 2017 Birmingham, UK (Generic-Biosimilars 2017 ) slated on which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality

GENERICS-BIOSIMILARS 2017 is the biggest Pharmaceutical meeting of the worldwide Pharma industry, drawing in participants from around the world. This Platform gives a one of a kind gathering to nonexclusive pharmaceutical officials from around the globe to arrange and hear incredibly famous specialists talking about the most recent knowledge into the universal business, legitimate, and administrative advancements concerning the nonspecific pharmaceutical part.

Generic Pharma 2017 is the most settled and driving nonspecific procedure gathering in Germany. It joins senior officials from the Generic and biosimilar industry to give new experiences, future market patterns, creative business techniques and open doors for development for Pharmaceutical Industry. This includes Generic Drugs, Generic Pills and Generic Medication, Office of Generic Drugs, Biologics & Biosimilars, Quality Control, Array of Clinical Trials in Biosimilars 

Conference Series LLC Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. To know more about the conference series visit: http://conferenceseries.com/

Track -1: Generic Drugs, Generic Pills and Generic Medication:

A nonexclusive medication (nonspecific medications, short: generics prescriptions ) is a medication characterized as "a medication item that is tantamount to a brand/reference recorded medication item in measurements frame, quality, quality and execution attributes, and planned utilize." It has likewise been characterized as a term alluding to any medications showcased under its concoction name without publicizing or to the compound cosmetics of a generic medication as opposed to the promoted mark name under which the medication is sold. Despite the fact that they may not be connected with a specific organization, nonspecific medications are liable to the directions of the administrations of nations where they are apportioned. Worldwide nonspecific is marked with the name of the maker and the received name (non-restrictive name) of the medication. A nonspecific medication and OTC Drugs must contain indistinguishable dynamic fixings from the first definition.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines AssociationInternational Generic and Biosimilar Medicines AssociationGeneric Pharmaceutical AssociationEuropean Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECUEuropean Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of BiotechnologyAmerican Association of Pharmaceutical ScientistsAssociation of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association.

Track 2: Office of Generic Drugs (OGD):

A nonexclusive pharmaceutical  is a medication that is precisely the same as the brand-name tranquilizes, however must be delivered after the brand-name medication's patent has terminated. A Generic   medication  and OTC Medications is the same as a brand-name tranquilize in:

  • measurement
  • wellbeing  
  • quality
  • the way it works
  • the way it is taken
  • the way it ought to be utilized

A medication organization grows new medications and pharmaceutical as brand-name tranquilizes under patent assurance where there is not a single prescription mistake are in sight. This thus secures the interest in the medication's advancement by giving the medication organization the sole appropriate to make and offer the brand-name sedate while the patent is essentially.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 3: Biologics & Biosimilars:

Biosimilars the Generic form of organic is the new popular expression in pharmaceutical industry. Biosimilars are exceptionally like authorized reference item not withstanding minor contrasts in clinically idle parts; additionally there are no clinically significant contrasts between the organic and the reference item as far as wellbeing, virtue, and strength. This track incorporates: Licensing of Biosimilars, Biomarkers direction, Patent issues, BLA petitioning for Biosimilars, Regulatory prospects of BRIC nations, a worldview of customary generics to Biosimilars, Biologics& Bio waiver endorsement for Biosimilars and different parts of Biosimilar endorsements.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 4: Pharmacology and Drug Development.

Pharmacology is the branch of solution and science worried with the investigation of medication action where a medication can be comprehensively characterized as any man-made, characteristic, or endogenous (from inside body) particle which applies a biochemical and additionally physiological impact on the cell, tissue, organ, or living being (once in a while the word pharmacon is utilized as a term to envelop these endogenous and exogenous bioactive species). Sedate improvement is the way toward conveying another pharmaceutical medication to the market once a lead compound has been distinguished through the procedure of medication revelation. It incorporates pre-clinical research on microorganisms and creatures, petitioning for administrative status, for example, by means of the United States Food and Drug Administration for an investigational new generic medication to start clinical trials on people, and may incorporate the progression of acquiring administrative endorsement with another medication application to showcase the medications and Increase Global  Pharma Market

Related Conferences:

9th World Congress on Pharmacology August 07-09, 2017 Paris, France; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain;5th International Conference and Exhibition on Pharmacology and Ethnopharmacology Mar 23-25, 2017 Orlando, USA; 11th Annual Global Pharma Summit  August 17-18, 2017 San Francisco, USA; 9th Social Media in the Pharmaceutical Industry January 18 - 19, 2017London, UK; 2nd Pharma Market Research Conference USA February 1 - 2, 2017 Washington USA; 2nd Bioprocessing and Manufacturing Conference 2017April 10 - 12, 2017 Washington DC, USA; 6th FIP Pharmaceutical Sciences World Congress 2017 May 21 - 24, 2017 Stockholm, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 5: Array of Clinical Trials in Biosimilars.

clinical trial is an examination study that tests another restorative treatment or another method for utilizing a current treatment to check whether it will be a superior approach to counteract and screen for analyse or treat a disease1. For any new medication to enter in clinical trial, it must pass preclinical studies. Preclinical studies  of Biosimilars include in vitro (i.e. test-tube or Laboratory) studies and trials on creature populaces. Extensive variety of measurements of the study medication is given to creature subjects or to an in-vitro substrate with a specific end goal to acquire preparatory adequacy, poisonous quality and pharmacokinetic data and includes Preclinical Studies in Phase I-IV.

Related Conferences:

5th International Conference on Clinical Pharmacy October 23-24, 2017 Florida, USA; 1st International Conference on Biotech Pharmaceuticals October 23-25, 2017 Paris, France; World Congress on Biotherapeutics and Bioanalytical Techniques September 11-13, 2017 Dallas, USA;5th International Pharmacy Conference April 27-28, 2017 Las Vegas, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 2nd Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 3rd Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress 2017 May 21 - 24, 2017 Stockholm, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 6: GMP, GCP and Quality Control:

Good Manufacturing Practice is that part of quality management which ensures that products are consistently produced and controlled according to the quality standards appropriate to their intended use and as required by the marketing authorizationclinical trial authorization or product specification. Good Manufacturing practices conference aims at both production and Quality Control . Fact about Current Good Manufacturing Practices (cGMP) is aimed primarily at managing and minimizing the risks inherent in pharmaceutical manufacture to ensure the quality, safety and efficacy of products. FDA regulates the quality of pharmaceuticals very carefully. Current Trends in the FDA is the main regulatory standard for ensuring pharmaceutical quality, Patent Access Intellectual property & FDA Regulations.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA .

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 7: Patent Access& Intellectual property& FDA Regulations:

patent is an arrangement of select rights conceded by a sovereign state to an innovator or appointee for a constrained timeframe in return for point by point open divulgence of a creation. An innovation is an answer for a particular mechanical issue and is an item or a procedure. Licenses are a type of protected innovation. Regulatory affairs  is a comparatively new profession which developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. Regulatory Affairs  is involved in the development of new medicinal products from early on, by integrating regulatory principles and by preparing and submitting the relevant regulatory dossiers to health authorities.

Related Conferences:

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP  & Quality Control Sep 25-26, 2017 Chicago, USA; 3rd World Biosimilar Congress  May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in Pharmaceutical Industry  January 18 - 19, 2017 London, UK; 2nd Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 3rd Bioprocessing and Manufacturing Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress 2017 May 21 - 24, 2017 Stockholm, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 8: Quality Control/ R & D

Quality control, or QC for short, is a procedure by which elements audit the nature of all variables required underway. ISO 9000 characterizes quality control as "A piece of value administration concentrated on satisfying quality requirements, Quality control underscores testing of items to reveal deformities and answering to administration who settle on the choice to permit or deny item discharge, though quality affirmation endeavours to enhance and balance out creation (and related procedures) to maintain a strategic distance from, or possibly minimize, issues which prompted to the defect(s) in the principal place.[citation needed] For contract work, especially work granted by government organizations, Pharmaceutical Industry quality control issues are among the top purposes behind not recharging an agreement manufacturing, Other elements have added to the feeling that the pharmaceutical business imaginative execution has declined. Over the previous decade, a developing offer of the business' R&D yield has comprised of incremental enhancements to existing generic medications  instead of new sub-atomic substances. Execution measures that consider just altogether new medications, for example, the quantity of NME endorsements every year—miss that move and underestimate the business' R&D Field

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association.

Track 9: Pharma Pricing & Market Access:

Pharma Pricing & Market Access general change in Pharma Industry   in connection to payers is the move from volume to esteem. In estimating terms, this is a move from a compensation for-pill to a compensation for-execution show. Basically, instalment will be allowed to items that exhibit esteem as far as enhanced wellbeing results or brought down social insurance cost Generic Medication and in addition that perform superior to less productive and less compelling contenders. Specialists bring up that numerous healing facility methodologies are as of now measured on execution, thus the same ought not to out of the ordinary with pharmaceutical items.

Related Conferences:

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP  & Quality Control Sep 25-26, 2017 Chicago, USA; 3rd World Biosimilar Congress  May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in Pharmaceutical Industry  January 18 - 19, 2017 London, UK; 2nd Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 3rd Bioprocessing and Manufacturing Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress 2017 May 21 - 24, 2017 Stockholm, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 10: Licensing, Manufacturing& Health Economics.

Health economics is a branch of Pharmacoeconomics concerned issues identified with productivity, viability, Quality  esteem and conduct in the generation and utilization of wellbeing and social insurance. In expansive terms, wellbeing financial analysts concentrate on the working of medicinal services frameworks and wellbeing influencing practices, for example, smoking and so on and a huge concentration of wellbeing financial aspects of Pharmaceutical Industry and  microeconomic assessment of the estimation of individual medications & Global Pharma Market . The states in Europe evaluate certain new and existing pharmaceuticals and gadgets utilizing financial assessments by wellbeing innovation by health technology assessments

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 11: Generics& Biosimilars Industry Strategy:

The "Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report presents an in-depth assessment of the generic drugs and Analysis of key therapeutic areas and leading generic drugs  pufecosystem including technology, economics, key trends, market drivers, challenges, investment potential, regulatory landscape, leading therapies, Pharmaceutical Industry  opportunities, future road map, Following key trends, market drivers, challenges, Analysis of key therapeutic areas and leading generic trends ,value chain, ecosystem player profiles and strategies and  Regulatory landscape of global trends  throughout the globe The report also presents market size forecasts for generic drugs from 2017 through to 2030. The forecasts are segmented for over 10 therapeutic areas, 3 brand classifications, 5 regions and 25 leading countries.

Related Conferences:

11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP  & Quality Control Sep 25-26, 2017 Chicago, USA; 3rd World Biosimilar Congress  May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry  January 18 - 19, 2017 London, UK; 2nd Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 3rd Bioprocessing and Manufacturing Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress 2017 May 21 - 24, 2017 Stockholm, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 12: Global Generic Trends & Global Pharma Market

The worldwide pharma market is experiencing major auxiliary changes with critical ramifications for India and Indian organizations. North America keeps on being the biggest Pharma Market  advertise on the planet adding to about 33% of the $1 trillion in yearly worldwide pharma deals in esteem terms. Be that as it may, with the fast pace of development in Pharma Industry  deals in Asia in the course of the most recent five years and the normal development in the medium-term future, the focal point of gravity for the pharma market is gradually moving toward Europe is probably going to soon surpass North America as far as general pharma deals. This is a pattern that is probably going to proceed for years to come because of expansive macroeconomic drivers, for example, populace and salary development. Beyond any doubt Japan and China will keep on dominating pharma deals in Asia. For instance, with yearly pharma offers of over $80 billion, China is as of now more than five times the extent of the Indian local pharma showcase regarding esteem. Be that as it may, quick yearly market income development rates of more than 10–12 for every penny in nations, for example, India are probably going to see an extending enthusiasm by worldwide Pharma Industy organizations in other European Pharma markets including from all worldwide Pharmaceutical Industry.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6th FIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control  Sep 25-26, 2017 Chicago, USA

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association.

Track 13: Innovative techniques in biosimilars

biosimilar is an organic item very like an affirmed natural item, known as a kind of perspective item, with no clinically significant contrasts as far as wellbeing and viability. In the U.S., if a natural compound exhibits practically identical information to a U.S. Nourishment and Drug Administration (FDA)- authorized item from expository, preclinical and clinical reviews, it will be acknowledged as a biosimilar after termination of trend-setter licenses through a curtailed course. Tradable natural items are likewise Generics &biosimilars however should meet extra criteria to coordinate the reference item. Interchangeable can be substituted for the reference item without a medicine from a social insurance supplier.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 14: Biosimilar development challenges

Biosimilars are surmounting pharmaceutical business division from most recent three decades and deals appear to extend coherently. Advances in the biotechnology prompt to change and exposure of new natural items (biosimilars) to treat diverse life-debilitating illnesses. Biosimilars are organic medications that are conveyed after expiry of the patent of affirmed pioneer and include Hatch-Waxman act is the amendment to Federal, Food, Drug and Cosmetics act which established the modern system of approval of generics through Abbreviated New Drug Applications (ANDAs).

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 15: Case Study Mitigating Risk in Biosimilar Development

With an expected $67 billion worth of licenses on organic items lapsing before 2020 and governments forced to diminish quickly rising human services costs, biosimilars speak to a noteworthy open door for the pharmaceutical business. Biosimilars are exceptionally like their authorized reference item not withstanding minor contrasts as excipients in the plan; likewise there are no wonderful contrasts between the biologicals and the reference item as far as wellbeing, immaculateness, and strength. However, until a global development strategy is adopted, regulatory, therapeutic and legal challenges remain.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track -16: Pharmacovigilance & Safety of Biosimilars

Biosimilars are interlinked with FDA activities that have as of now been declared to incorporate upgraded following and follow-up of post market issues, arranged changes in AERS, and pilots of new post advertise medicate observing systems. Current difficulties in pharmacovigilance, adverse medication responses with pharmaceutical items, Biosimilar rules for Pharmacovigilance practice and pharmacoepidemiology are the focuses that should be laid accentuation in this session.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 17: Biosimilars Uptake & Patient Safety:

Biosimilar engineers and their outsourcing accomplices must know about the picked nation's administrative scene, and have broad information of any current biosimilar endorsement pathway and the most recent administrative organization rules. Furnishing administrative experts with endorsements of investigation (CoA) for a U.S.- advertised comparator could challenge. Generics as opposed to European practice, U.S. makers tend not to make CoAs accessible to parties required in the production network or bolster the improvement of a contender by discharging Coast for clumps acquired for clinical trials. Giving family proclamations to the reference item more often than not is acknowledged as an option.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 18: Protein biotherapeutics & Biosimilars

Biotherapeutics more often than not alludes to helpful materials created utilizing organic means, including recombinant DNA innovation. Biosimilars Deviates’ are the biotherapeutics are fundamentally operators, used to treat and maintain a strategic distance from human malady by interrelating with the microbial environment of the host. Biotherapeutics can target particular particles inside the human body, and have a decent reputation with patient wellbeing. Fabricating biotherapeutics is mind boggling and as they are bigger derivate of the Medicines and their products mixes in both size and structure, and can be touchy to ecological conditions.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 19: Developing Biosimilars and Biobetters

Biosimilars are surmounting pharmaceutical business division from most recent three decades and deals appear to extend coherently. Advances in the biotechnology prompt to change and exposure of new natural items (biosimilars) to treat diverse life-debilitating illnesses. Biosimilars are organic medications that are conveyed after expiry of the patent of affirmed pioneer and include Hatch-Waxman act is the amendment to Federal, Food, Drug and Cosmetics act which established the modern system of approval of generics through Abbreviated New Drug Applications (ANDAs).

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Track 20: Biosimilars Differentiated Through Novel Drug Delivery Technologies

Biosimilars is a biologic therapeutic item which is duplicate of a unique item that is made by an alternate organization. Biosimilars are formally affirmed renditions of unique biosimilar trend-setter items, and can be fabricated when the first item's patent lapses. This session should be profoundly valuable for the biosimilar business scientists to redesign themselves on the most recent research upgrades from around the globe. This session additionally discovers put for all the biosimilar shows connected with the field of biosimilars and biologics. The inalienable insecurity nature of another medication will adjust its coveted frame into undesired shape when exhibited in a reasonable measurements shape with the excipient/s upon capacity.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association.

Track 21: Chronicles of a Biosimilar Production Facility 

Biologics restorative items created through rDNA innovation as recombinant protein-based solutions that have been in clinical use since the mid-1980s as unique biopharmaceuticals have extraordinarily added to the treatment of extreme metabolic and degenerative infections. The late close of the information assurance or licenses for the greater part of them made open doors for the advancement of duplicate adaptations of unique biopharmaceuticals with comparative biologic movement (named biosimilars). Generation of these new items is relied upon to take care of overall demand, advance market rivalry, keep up the impetuses for development, and maintain the human services frameworks.

Related Conferences:

3rd World Biosimilar Congress May 23–24 , 2017 San Diego, USA; 12th Biosimilars Summit January 24 25, 2017 Alexandria, USA ; 2nd Biosimilars Congregation March  01-02 ,2017 London, UK; 9 th Social Media in the Pharmaceutical Industry January 18 - 19, 2017 London, UK; 10th Pharma Market Research Conference February 1 - 2, 2017 Washington USA; 7th Bioprocessing and Manufacturing  Conference April 10 - 12, 2017 Washington DC, USA ; 6thFIP Pharmaceutical Sciences World Congress May 21 - 24, 2017 Stockholm, USA; 11th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Feb 27- 28, 2017 Amsterdam, Netherlands; 9 th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 9 th  International Conference and Exhibition on Pharmacovigilance & Drug Safety July 17-19, 2017 Munich, Germany; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 6th International Summit on GMP, GCP & Quality Control Sep 25-26, 2017 Chicago, USA.

Related Societies:

Generic and Biosimilar Medicines Association; International Generic and Biosimilar Medicines Association; Generic Pharmaceutical Association; European Federation Of Pharmaceutical Industries and Associations ;EUROPEAN GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION ;Pharmaceutical Group of European Union PGECU; European Association of Euro-Pharmaceutical Companies ;European Industrial Pharmacists Group ;European Federation of Biotechnology; American Association of Pharmaceutical Scientists; Association of International Pharmaceutical Manufacturers ;International Research-Based Pharmaceutical Manufacturers Association

Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners

About Conference

Conference Series LLC invites all the participants from all over the world to attend  “2nd International Conference on Generic Drugs and Biosimilars’’ (Generic Pharma 2017) slated on August 24-25, 2017 at Birmingham, UK which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality

Conference Series LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 1000+ Open access journals which contain over 70000 eminent personalities, reputed scientists as editorial board members, 1200 Symposium & Workshops and 5 million followers. To know more about the conference series visit: http://conferenceseries.com/. To its credit Conference Series LLC invites all the participants across the globe to attend the " 2nd International Conference on Generic Drugs and Biosimilars

Generic Pharma 2017 conveys recent developments in Generic drug marketing and production of generic drugs and contract manufacturing. A complete knowledge of a scientific discipline that described the effects of generic drug marketing and generic Pharma now explores the Scope of generic drug marketing in industry. Generic Pharma 2016 provides detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major country markets these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the generic drug market. The wider economic environment is also taken into account.

A 2 day gathering that examines the future market patterns, creative business methodologies and open doors for development of moderate medications. Pharma pioneers want the substance and roundtable examinations, yet remain for the systems administration and air.
 
This meeting is formally the biggest key nonexclusive gathering in the business and will give members a thorough survey of business methodology for moderate meds.
  • Get your image before senior chiefs
  •  Break into the lucrative Generic Medicines industry
  •  Position your organization as an industry pioneer
  •  Make deals leads and convey an arrival on venture
  • Connect with your objective market in the locale.
You will meet:
  • Board level and senior agents from nonspecific and biosimilar pharmaceutical organizations
  • Venture banks
  • Law offices
Your chance:
  • Develop long haul connections by organizing gatherings with top prospects
  • Talk and show thought administration
  • Increment mark mindfulness and situating

     Merger and Acquistion Scenerio in Pharmaceutical Industry-Generic Pharma 2017

Market Analysis

                  2nd International Conference on Generic Drugs and Biosimilars

                                                                       August 24-25, 2017 Birmingham, UK

                   Theme: Merger and Acquisition Scenerio in Pharmaceutical Industry

Generic Pharma 2017 conveys recent developments in

A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights.

Already prevalent in the U.S., Europe and much of the developing world, generic drugs are now finding their way into previously untapped markets such as Japan, largely driven by regulatory efforts to reduce healthcare costs.

The "Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report presents an in-depth assessment of the generic drugs ecosystem including technology, economics, key trends, market drivers, challenges, investment potential, regulatory landscape, leading therapies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for generic drugs from 2015 through to 2030. The forecasts are segmented for over 10 therapeutic areas, 3 brand classifications, 5 regions and 25 leading countries.

Scope and Importance:-

After the expiry of patent or marketing rights of the patented drug, generic drugs are marketed. Generic drugs are available at affordable prices with maintaining quality. These ‘Generic formulations balance public interest as critical disease like cancer, AIDS etc. It is widely accepted both developed and developing countries. An estimated half of all prescriptions in the USA are now filed with approved generic drugs. In order to market drugs, U.S. generic manufacturers must have a permit and approval from the Food and Drug Administration (FDA) indicating that the active ingredient is approximately the same as that of the brand name. The determination of drug approval is made according to whether it is pharmaceutically equivalent, bio-available, and bioequivalent. World Health Organization (WHO) provided a definition for counterfeit drugs.

About Venue:

Birmingham is also a centre for commerce, culture, education, tourism and web traffic. Messe Frankfurt is one of the world's largest trade fairs at 578,000 square metres and ten exhibition halls, a central logistics centre and an attached convention centre. Major trade fairs include the Frankfurt Motor Show, the world's largest motor show, and the Frankfurt Book Fair, the world's largest book fair. Frankfurt is also home to many cultural and educational institutions including the Johann Wolfgang Goethe University and Frankfurt University of Applied Sciences, many museums (e.g. Städel, Naturmuseum Senckenberg, Schirn Kunsthalle Frankfurt, Goethe House), and two major botanical gardens, the Palmengarten, which is UK largest, and the Botanical Garden of the Goethe University.

Societies Associated with Generic Pharma:

  • Canadian Generic Pharmaceutical Association (CGPA)
  • International Generic Pharmaceutical Alliance - IGPA
  • European Generic medicines Association
  • Generic Pharmaceutical Association - Fierce Pharma
  • British Generic Manufacturers Association
  • Worldwide Pharmaceutical Association -
  • Generic Pharmaceutical Association (GPhA )

Country wise Statistics (European):

  • European Association of Faculties of Pharmacy (EAFP)
  • European Association for Health Information and Libraries (EAHIL)
  • European Association of Hospital Pharmacists (EAHP)
  • European Biosafety Association (EBSA)
  • European Federation for Medicinal Chemistry (EFMC)
  • European Federation for Pharmaceutical Sciences (EUFEPS)
  • European Pharmaceutical Students Association (EPSA)
  • European Society of Clinical Pharmacy (ESCP)
  • European Society of Regulatory Affairs (ESRA)
  • Pharmaceutical Group of the European Union (PGEU)

Worldwide Statistics (International):

  •     Association de Pharmacie Galénique Industrielle (APGI)
  •     Controlled Release Society (CRS)
  •     Institute of Pharmacy Management International (IPMI)
  •     International Academy of Compounding Pharmacists (IACP)
  •     International Association for Pharmaceutical Technology (APV)
  •     International health Association
  •     International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
  •     International Federation of Pharmaceutical Wholesalers (IFPW)
  •     International Pharmaceutical Excipients Council (IPEC)
  •     International Pharmaceutical Federation (FIP)
  •     International Pharmaceutical Students Federation (IPSF)
  •     International Society for Medical Publication Professionals (ISMPP)
  •     International Society of Oncology Pharmacy Practitioners (ISOPP)
  •     International Society for Pharmaceutical Engineering (ISPE)
  •     International Society for Pharmacoepidemiology (ISPE)
  •     International Society for the History of Pharmacy (ISHP)
  •     International Society for the Study of Xenobiotics (ISSX)
  •     International Society of Pharmaceutical Compounding (ISPhC)
  •     International Young Pharmacists' Group (YPG)
  •     Parenteral Drug Association (PDA)
  •     Regulatory Affairs Professionals Society (RAPS)
  •     Society for Biomolecular Sciences (SBA)
  •     Society for Cell Science (SFCS)
  •     Society for Translational Oncology (STO)

Statistical Representation:

Industries Associated with Pharmaceutical Research:

A. City statistics:

 List of Pharmaceutical companies in Birmingham, UK

  • Almirall
  • Cinfa Laboratories
  • Curaxys                  
  • Esteve
  • Grifols
  • Inibsa
  • SOM Biotech
  • Zeltia

      Country Statistics:

Worldwide Statistics:

Pharmaceutical Companies Worldwide

Abbott Laboratories

Almirall

AbbVie

Alphapharm

Acadia Pharmaceuticals

Altana Pharma AG

Actavis

Amgen

Actelion

Amico Laboratories

Advaxis

Anavex Life Sciences

Ajanta Pharma

Apotex Inc.

Alcon

Astellas Pharma

Alexion Pharmaceuticals

AstraZeneca

Alkaloid

Avax Technologies

Alkermes

Avella Specialty Pharmacy

Allergan

Axcan Pharma

Alliance Boots

Aurobindo Pharma

Bargn Farmaceutici Phils Co

Cadila Healthcare

Barr

Celgene

Basi

Cephalon

Bausch & Lomb

Chiesi Farmaceutici S.p.A.

Baxter International

Chugai Pharmaceutical Co.

Bayer Schering Pharma AG

CinnaGen

Beximco Pharmaceuticals Ltd

Cipla

Bial

CoCo Therapeutics

Biocon

Covance

Biogen Idec

Crucell

Biolex

CSL Limited

Bionovo

Daiichi Sankyo

Biotecnol

Dainippon Sumitomo Pharma

Biovail

Dawakhana Shifaul Amraz

Biovitrum

Debiopharm

Bluepharma

Diabetology Ltd

Boehringer-Ingelheim

Diffusion Pharmaceuticals

Bosnalijek

Dr. Reddy's Laboratories

Bristol-Myers Squibb

jenapharm

Ego Pharmaceuticals

Help Remedies

Eisai (company)

Hetero Drugs

Elder Pharmaceuticals

Hexal Australia

Eli Lilly and Company

Hikma Pharmaceuticals

Elorac, Inc.

Hoffmann–La Roche

Emergent BioSolutions

Hovione

Endo Pharmaceuticals

Ipca Laboratories

Eskayef Bangladesh Limited

Incepta Pharmaceuticals

F. Hoffmann–La Roche Ltd., which owns Genentech and Chugai Pharmaceuticals

Institute for OneWorld Health

Ferring Pharmaceuticals

Intas Biopharmaceuticals

Fresenius Kabi

Intercytex

Fresenius Medical Care

Interphil Laboratories

Galderma Laboratories

Janssen Pharmaceutica Products, a subsidiary of Johnson & Johnson

Getz Pharma

Jenapharm, a subsidiary of Bayer Schering Pharma

Gilead Sciences

JN-International Medical Corporation

GlaxoSmithKline

Johnson & Johnson

Glenmark Pharmaceuticals

Julphar

GPC Biotech

Lupin Limited

Grifols

Menarini

Gulf Pharmaceutical Industries (Julphar)

Merck & Co.

3M Pharmaceuticals

Merck KGaA

MannKind Corporation

Mitsubishi Pharma

McGuff

Mylan

Medinfar

Novartis

Melior Discovery

Novo Nordisk

NovaBay Pharmaceuticals

Noxxon

Octapharma

Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson

Orexo

Otsuka Pharmaceutical Co.

Orion Pharma

Pharmacosmos

Panacea Biotec Ltd

Pierre Fabre Group

Par Pharmaceutical

Piramal Healthcare

Patheon

Pliva

Perrigo

Procter & Gamble

Pfizer

Purdue Pharma

Pharma Medica

Renovo

Pharma Nord

Respa Pharmaceuticals

Gedeon Richter Ltd.

Rubicon Research

Ranbaxy Laboratories, generics arm  of  Daiichi Sankyo

Reckitt Benckiser

Regeneron Pharmaceuticals

Solvay Group

Salix Pharmaceuticals

Square Pharmaceuticals

Sanofi

STADA Arzneimittel

Sunovion

Strides Arcolab

Serum Institute of India

Sun Pharmaceutical

Servier Laboratories

Takeda Pharmaceutical Co.

Shionogi

Tasly

Shire plc

Teva Pharmaceuticals

Sigma Pharmaceuticals

Torrent Pharmaceuticals

Sinopharm Group

Vertex Pharmaceuticals

UCB

Vion Pharmaceuticals, Inc.

Unichem Laboratories

Wallace Pharmaceuticals

UNILAB, also known as United Laboratories

Wockhardt

Valeant Pharmaceuticals International, formerly ICN Pharmaceuticals

Yuhan Corporation

VAV Life Sciences

Zandu Pharmaceuticals

Veloxis Pharmaceuticals

Zentiva

 

Statistical Representation:

Market Value on Pharmaceutical Research:

Country Statistics:

This statistic depicts the global leading generics manufacturers' revenues in 2014-2015. In that year, Teva's generic division reported some 9.1 billion U.S. dollars of revenue worldwide. Thus, Pharmexcil is the world's leading generic manufacturer.

Worldwide Statistics:

Top 20 pharmaceutical companies based on worldwide prescription drug revenues in 2016 (in million U.S. dollars)

The top pharmaceutical companies in the world are Novartis, Pfizer, and Sanofi, based on 2014 pharmaceutical revenues. The companies generated 51.3 billion U.S. dollars, 44.9 billion U.S. dollars, and 40 billion U.S. dollars, respectively, in the year 2014.

Pharmaceutical companies are best known for manufacturing pharmaceutical drugs. These drugs have the aim to diagnose, to cure, to treat, or to prevent diseases. The pharmaceutical sector represents a huge industry, with the global pharmaceutical market being worth nearly one trillion U.S. dollars. The best known top global pharmaceutical players are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Most of these companies are involved not only in pure pharmaceutical business, but also manufacture medical technology and consumer health products, vaccines, etc. For example, Johnson & Johnson makes most of its revenues through medical devices, diagnostics and consumer health products.

Market Growth of Pharmaceutical Research in the last and upcoming ten years

Pharmaceuticals are one of the world's most profitable industries. During the last 30 years, the industry has spent billions of dollars on research and reaped billions in return. In 2008 alone, the pharmaceutical industry sold $773 billion in products worldwide-a number that has consistently grown for the past 8 years and is projected to increase again by 2.5 to 3.5 percent in 2017, according to the drug market research firm IMS Health.

But the process that turns research dollars into medicines is a slow and often arduous one. It now takes an average of 12 to 15 years and up to $1.7 billion for a drug to go from discovery to market, according to The Pharmaceutical Research and Manufacturers of America. And despite all the time and money invested, only a handful of drugs are approved by the FDA each year.

The arduous drug approval process reveals a central fact about Big Pharma: it's one of the most intensely regulated industries in the world. The U.S. Food and Drug Administration (FDA) and its European Union counterpart, the European Medicines Agency (EMEA), govern every aspect of a drug's development-from chemicals used in the drug and clinical study instructions, called protocols, to packaging components and marketing materials. This strict oversight is meant to protect patient safety, and pharmaceutical Sector.

Past Conference Report

Generic Pharma 2016

Conference Series LLC organized International Conference and Expo on Generic Drug Market and Contract Manufacturing during Nov 07- 09, 2016 at Barcelona, Spain that got brilliant response. Eminent Scientists, researchers, business professionals and scholar students were participated during this prestigious conference. With the support and steerage of Organizing Committee Members, Editorial Board Members and amaze displays of all participants this outstanding summit became additional spectacular. The theme of the conference “Current and Future Global Drug Market Trends and Manufacturing” was dilated across the world by speeches from the participants and with boost of media partners and collaborators.

The conference was marked with the presence of far-famed scientists, proficient researchers, students and delegates representing from different countries ultimately driving the event into the trail of success.

Generic Pharma 2016 Organizing Committee would like to thank the Moderator of the conference Philip Armendi, Allergan, USA, chair and co-chair of the conference and all other attendees who contributed a lot for the smooth functioning of the event.

Conference Series LLC would like to convey a great appreciation to following honourable guests and Keynote speakers

  • Kurt R Karst, Hyman Phelps and McNamara P C, USA
  • Anka G Ehrhardt, Bristol-Myers Squibb Company, USA
  • Isadore Kanfer, Rhodes University, South Africa
  • Frank Sinner, Joanneum Research GmbH, Austria
  • Jianguo Yang, ABPRO, China
  • Walid El Azab, STERIS Corporation, Belgium
  • Adnan Sabir, Pharma Consulting Services, USA
  • Murray Ducharme, Learn & Confirm Inc., Canada
  • Se Jin Lee, Korea Conformity Laboratories, Republic of Korea
  • Olubunmi Ogbodu, University of Venda, South Africa

Conference Series LLC has taken the privilege of felicitating Generic Pharma 2016 Organizing Committee, Editorial Board Members, Honourable guests and Keynote Speakers who supported for the success of this event. With property excitement for grand success of this outstanding conference it's glad to announce next annual meeting 2nd International Conference on Generic Drugs and Biosimilars to be control throughout August 24-25, 2017 Birmingham, UK, with the theme “Merger and Acquisition Scenerio in Pharmaceutical Industry”.

&

2nd International Conference on Generic Drugs and Biosimilars August 24-25, 2017 Birmingham, UK

For more details visit: http://generic-market.pharmaceuticalconferences.com/

               The Future Of Genericpharma: Key Opportunities & Emerging Therapies-Generic Pharma 2017


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date August 24-25, 2017

Speaker Opportunity

Day 1 Day 2

Supported By

Journal of Developing Drugs Drug Designing: Open Access Journal of Bioequivalence & Bioavailability

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner